Toward standardization of carbohydrate-deficient transferrin (CDT) measurements: I. Analyte definition and proposal of a candidate reference method.
An alcohol-associated change in the serum transferrin glycoform pattern, carbohydrate-deficient transferrin (CDT), is used as a biomarker of chronic moderate to heavy alcohol consumption. A current limitation in CDT analysis is the lack of standardization, which hampers clinical and analytical comparison between studies. This situation prompted initiation of a Working Group (WG) on CDT Standardization under the auspices of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). The standardization work aims to define and validate the analyte, select a reference method, work out procedures for the production of reference materials, and make suggestions for the clinical usage of CDT. The first recommendation of the WG is that disialotransferrin should be the primary target molecule for CDT measurement and the single analyte on which CDT standardization is based. It is further recommended that HPLC should be the analytical principle considered as the basis of an interim reference method until a suitable mass spectrometric reference method is established. In clinical use, CDT should be expressed in a relative amount (% CDT), to compensate for variations in the total transferrin concentration.
Jeppsson
Jan-Olof
JO
Malmö University Hospital, Malmö, Sweden.
Arndt
Torsten
T
Schellenberg
François
F
Wielders
Jos P M
JP
Anton
Raymond F
RF
Whitfield
John B
JB
Helander
Anders
A
D006801:Humans; D012015:Reference Standards; D014168:Transferrin / Q000031:analogs & derivatives* / Q000592:standards
D014168:Transferrin; C056759:carbohydrate-deficient transferrin